Skip to content
OpenCapital
Get started

iRadimed IRMD Free cash flow margin

Free cash flow margin at other companies

GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
7.2%—
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp
ICU Medical logo
ICU MedicalICUI
4.2%-1.2pp
ITG
Integer HoldingsITGR
5.4%-1.0pp
RadNet logo
RadNetRDNT
5.1%+0.9pp
iRhythm Holdings, Inc. logo
iRhythm Holdings, Inc. IRTC
2.4%—

Other financials

Income statement

See full
Revenue$22.0M+12.6%
Gross profit$16.8M+13.3%
Operating income$7.2M+33.2%
Net income$5.8M+24.1%
EPS (diluted)$0.45+21.6%

Balance sheet

See full
Cash & equivalents$56.4M+12.0%
Total debt$59.2K-96.9%
Total equity$98.5M+9.4%
Total assets$114.4M+12.4%

Cash flow

See full
Operating cash flow$8.3M+93.2%
CapEx$403.0K-89.1%
Free cash flow$7.9M+1,226%

Valuation

See full
Market cap$1.21B+63.4%
P/E51.3×+13.8×
P/S14×+4.2×

Profitability

See full
Gross margin76.8%-0.1pp
Operating margin32.4%+2.3pp
Net margin27.4%+1.0pp

Returns & leverage

See full
Return on equity25%+1.2pp
Debt / equity0×0.0×
Current ratio7.1×-1.7×

Where this comes from

Calculated from iRadimed’s reported figures.

free cash flow/total revenue=28.4%

Based on trailing twelve months.

The official record: iRadimed’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about iRadimed's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is iRadimed's free cash flow margin?
iRadimed (IRMD) reported free cash flow margin of 28.4% in Q1 2026.
How has iRadimed's free cash flow margin changed year-over-year?
iRadimed's free cash flow margin increased by 46.0% year-over-year, from 19.4% to 28.4%.
What is the long-term trend for iRadimed's free cash flow margin?
Over 5 years (2020 to 2025), iRadimed's free cash flow margin has grown at a 3.9% compound annual growth rate (CAGR), from 16.9% to 20.5%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.